Experiment 456132
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Empty organism |
| Citation | LEDERLE,FA: APPLEGATE,WB: GRIMM JR,RH:. (1993). RESERPINE AND THE MEDICAL MARKETPLACE.. 153(6) |
| Amount utilized | |
| Compound isolated | |
| Disease | DOSES OF 0.05-0.125 MG/D ARE THERAPEUTIC. DEPRESSION OCCURS IN <5%, AN INCIDENCE NO GREATER THAN THAT SEEN WITH BETA-BLOCKERS. NASAL CONGESTION OCCURS IN 15%. LETHARGY, IMPOTENCE AND DYSPEPSIA ARE UNCOMMON SIDE-EFFECTS. CMPD APPEARS AS WELL TOLERATED AS OTHER NEWER ANTIHYPERTENSIVES, BUT IS CHEAPER AND CORPORATE ADVOCATE. |
| Dose amount | VAR |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Dose expression | DOSE |